194 related articles for article (PubMed ID: 27416100)
1. Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
Spaan M; Hullegie SJ; Beudeker BJ; Kreefft K; van Oord GW; Groothuismink ZM; van Tilborg M; Rijnders B; de Knegt RJ; Claassen MA; Boonstra A
PLoS One; 2016; 11(7):e0159243. PubMed ID: 27416100
[TBL] [Abstract][Full Text] [Related]
2. Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis.
Beudeker BJB; van Oord GW; Arends JE; Schulze Zur Wiesch J; van der Heide MS; de Knegt RJ; Verbon A; Boonstra A; Claassen MAA
Liver Int; 2018 Mar; 38(3):458-468. PubMed ID: 28792648
[TBL] [Abstract][Full Text] [Related]
3. Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection.
Khlaiphuengsin A; Chuaypen N; Sodsai P; Reantragoon R; Han WM; Avihingsanon A; Tangkijvanich P
PLoS One; 2020; 15(12):e0244112. PubMed ID: 33382729
[TBL] [Abstract][Full Text] [Related]
4. Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.
Bolte FJ; O'Keefe AC; Webb LM; Serti E; Rivera E; Liang TJ; Ghany M; Rehermann B
Gastroenterology; 2017 Nov; 153(5):1392-1403.e2. PubMed ID: 28780074
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the NK cell pool in HIV/HCV co-infection.
Kaczmarek DJ; Kokordelis P; Krämer B; Glässner A; Wolter F; Goeser F; Lutz P; Schwarze-Zander C; Boesecke C; Strassburg CP; Rockstroh JK; Spengler U; Nattermann J
PLoS One; 2017; 12(4):e0174465. PubMed ID: 28380039
[TBL] [Abstract][Full Text] [Related]
6. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
[TBL] [Abstract][Full Text] [Related]
7. Attrition of TCR Vα7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression.
Saeidi A; Tien Tien VL; Al-Batran R; Al-Darraji HA; Tan HY; Yong YK; Ponnampalavanar S; Barathan M; Rukumani DV; Ansari AW; Velu V; Kamarulzaman A; Larsson M; Shankar EM
PLoS One; 2015; 10(4):e0124659. PubMed ID: 25894562
[TBL] [Abstract][Full Text] [Related]
8. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
[TBL] [Abstract][Full Text] [Related]
9. CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals.
Kared H; Saeed S; Klein MB; Shoukry NH
PLoS One; 2014; 9(7):e101441. PubMed ID: 25007250
[TBL] [Abstract][Full Text] [Related]
10. Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting.
Balfour A; Schutz C; Goliath R; Wilkinson KA; Sayed S; Sossen B; Kanyik JP; Ward A; Ndzhukule R; Gela A; Lewinsohn DM; Lewinsohn DA; Meintjes G; Shey M
Front Immunol; 2021; 12():648216. PubMed ID: 33828558
[No Abstract] [Full Text] [Related]
11. Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients.
Merlini E; Cerrone M; van Wilgenburg B; Swadling L; Cannizzo ES; d'Arminio Monforte A; Klenerman P; Marchetti G
Front Microbiol; 2019; 10():1972. PubMed ID: 31555223
[TBL] [Abstract][Full Text] [Related]
12. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection.
Wong EB; Akilimali NA; Govender P; Sullivan ZA; Cosgrove C; Pillay M; Lewinsohn DM; Bishai WR; Walker BD; Ndung'u T; Klenerman P; Kasprowicz VO
PLoS One; 2013; 8(12):e83474. PubMed ID: 24391773
[TBL] [Abstract][Full Text] [Related]
13. MAIT be different-persisting dysfunction after DAA-mediated clearance of chronic hepatitis C virus infection.
Hofmann M; Thimme R
Eur J Immunol; 2016 Sep; 46(9):2099-102. PubMed ID: 27479232
[TBL] [Abstract][Full Text] [Related]
14. An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.
Kokordelis P; Krämer B; Körner C; Boesecke C; Voigt E; Ingiliz P; Glässner A; Eisenhardt M; Wolter F; Kaczmarek D; Nischalke HD; Rockstroh JK; Spengler U; Nattermann J
Hepatology; 2014 Mar; 59(3):814-27. PubMed ID: 24382664
[TBL] [Abstract][Full Text] [Related]
15. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
[TBL] [Abstract][Full Text] [Related]
16. Diverse Mucosal-Associated Invariant TCR Usage in HIV Infection.
Trivedi S; Afroz T; Bennett MS; Angell K; Barros F; Nell RA; Ying J; Spivak AM; Leung DT
Immunohorizons; 2021 May; 5(5):360-369. PubMed ID: 34045357
[TBL] [Abstract][Full Text] [Related]
17. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.
Cosgrove C; Ussher JE; Rauch A; Gärtner K; Kurioka A; Hühn MH; Adelmann K; Kang YH; Fergusson JR; Simmonds P; Goulder P; Hansen TH; Fox J; Günthard HF; Khanna N; Powrie F; Steel A; Gazzard B; Phillips RE; Frater J; Uhlig H; Klenerman P
Blood; 2013 Feb; 121(6):951-61. PubMed ID: 23255555
[TBL] [Abstract][Full Text] [Related]
18. Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.
Hengst J; Strunz B; Deterding K; Ljunggren HG; Leeansyah E; Manns MP; Cornberg M; Sandberg JK; Wedemeyer H; Björkström NK
Eur J Immunol; 2016 Sep; 46(9):2204-10. PubMed ID: 27296288
[TBL] [Abstract][Full Text] [Related]
19. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.
Eberhard JM; Hartjen P; Kummer S; Schmidt RE; Bockhorn M; Lehmann C; Balagopal A; Hauber J; van Lunzen J; Schulze zur Wiesch J
PLoS One; 2014; 9(11):e111323. PubMed ID: 25369333
[TBL] [Abstract][Full Text] [Related]
20. Successful direct-acting antiviral therapy in HIV/HCV co-infected patients fails to restore circulating mucosal-associated invariant T cells.
Cannizzo ES; Cerrone M; Merlini E; van Wilgenburg B; Swadling L; Ancona G; De Bona A; d'Arminio Monforte A; Klenerman P; Marchetti G
Eur J Immunol; 2019 Jul; 49(7):1127-1129. PubMed ID: 30985000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
